SAM
CLBT icon

Silvercrest Asset Management’s Cellebrite CLBT Stock Holding History

Silvercrest Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.32M Buy
638,386
+109,658
+21% +$1.45M 0.06% 364
2026
Q1 		$7.29M Buy
528,728
+50,903
+11% +$767K 0.05% 371
2025
Q4 		$8.62M Buy
477,825
+1,650
+0.3% +$29.6K 0.06% 344
2025
Q3 		$8.82M Buy
476,175
+116,496
+32% +$1.83M 0.06% 341
2025
Q2 		$5.75M Buy
359,679
+906
+0.3% +$16.2K 0.04% 408
2025
Q1 		$6.97M Buy
358,773
+150,745
+72% +$3.17M 0.05% 351
2024
Q4 		$4.58M Buy
+208,028
New +$4M 0.03% 433

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Silvercrest Asset Management's CLBT Position: Q2 2026 in Review

Silvercrest Asset Management increased its Cellebrite (CLBT) stake by 21% in Q2 2026, buying an estimated $1.45M and bringing the position to 638,386 shares worth $9.32M. The position accounts for 0.06% of the portfolio, ranked #364.

Silvercrest Asset Management first reported a position in CLBT in Q4 2024 and has held it in 7 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Silvercrest Asset Management held 638,386 shares of Cellebrite worth $9.32M as of Q2 2026.
  • Silvercrest Asset Management bought 109,658 Cellebrite shares in Q2 2026, an estimated $1.45M.
  • Cellebrite made up 0.06% of Silvercrest Asset Management's portfolio in Q2 2026, its #364 holding.
  • Silvercrest Asset Management first reported a position in Cellebrite in Q4 2024 and has held it in 7 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.